{
    "slug":  "weight-loss-drugs-insurance-coverage",
    "category":  "Health",
    "title":  "Medicare Now Covers Weight Loss Drugs After Historic Policy Change",
    "introText":  "Medicare will now cover GLP-1 weight loss drugs like Ozempic and Wegovy for obesity treatment. The historic policy change will make these medications accessible to millions of seniors who previously paid out-of-pocket.",
    "readingTime":  "7 Min Read",
    "author":  {
                   "image":  "/images/authors/author-2.webp",
                   "name":  "James Chen",
                   "role":  "Technology Correspondent"
               },
    "lastUpdated":  "December 17, 2025",
    "content":  [
                    {
                        "type":  "image",
                        "content":  "Medicare weight loss drug coverage",
                        "imageUrl":  "/images/news/healthy-food.webp",
                        "imageAlt":  "Healthy lifestyle"
                    },
                    {
                        "type":  "heading",
                        "content":  "Policy Change",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "CMS has announced Medicare Part D will cover FDA-approved weight loss medications starting in 2026. The change reverses a 2003 law that explicitly excluded obesity drugs from coverage."
                    },
                    {
                        "type":  "heading",
                        "content":  "Cost Impact",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "GLP-1 drugs cost $1,000+ monthly out-of-pocket. Medicare coverage will make them affordable for 15 million seniors with obesity. The policy is expected to cost Medicare $30 billion over five years."
                    },
                    {
                        "type":  "heading",
                        "content":  "Health Benefits",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "Studies show these medications reduce diabetes risk, heart disease, and other obesity-related conditions. Proponents argue coverage will reduce overall healthcare costs."
                    }
                ],
    "bookmarked":  false,
    "summary": "Medicare will now cover GLP-1 weight loss drugs like Ozempic and Wegovy, making them accessible to millions of seniors with obesity and reducing out-of-pocket costs."

}
